Accelerated Path to Cures

Nonfiction, Health & Well Being, Medical, Medical Science, Immunology, Computers, Advanced Computing, Computer Science
Cover of the book Accelerated Path to Cures by , Springer International Publishing
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783319732381
Publisher: Springer International Publishing Publication: April 25, 2018
Imprint: Springer Language: English
Author:
ISBN: 9783319732381
Publisher: Springer International Publishing
Publication: April 25, 2018
Imprint: Springer
Language: English

Accelerated Path to Cures provides a transformative perspective on the power of combining advanced computational technologies, modeling, bioinformatics and machine learning approaches with nonclinical and clinical experimentation to accelerate drug development. This book discusses the application of advanced modeling technologies, from target identification and validation to nonclinical studies in animals to Phase 1-3 human clinical trials and post-approval monitoring, as alternative models of drug development. As a case of successful integration of computational modeling and drug development, we discuss the development of oral small molecule therapeutics for inflammatory bowel disease, from the application of docking studies to screening new chemical entities to the development of next-generation in silico human clinical trials from large-scale clinical data. Additionally, this book illustrates how modeling techniques, machine learning, and informatics can be utilized effectively at each stage of drug development to advance the progress towards predictive, preventive, personalized, precision medicine, and thus provide a successful framework for Path to Cures. 

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Accelerated Path to Cures provides a transformative perspective on the power of combining advanced computational technologies, modeling, bioinformatics and machine learning approaches with nonclinical and clinical experimentation to accelerate drug development. This book discusses the application of advanced modeling technologies, from target identification and validation to nonclinical studies in animals to Phase 1-3 human clinical trials and post-approval monitoring, as alternative models of drug development. As a case of successful integration of computational modeling and drug development, we discuss the development of oral small molecule therapeutics for inflammatory bowel disease, from the application of docking studies to screening new chemical entities to the development of next-generation in silico human clinical trials from large-scale clinical data. Additionally, this book illustrates how modeling techniques, machine learning, and informatics can be utilized effectively at each stage of drug development to advance the progress towards predictive, preventive, personalized, precision medicine, and thus provide a successful framework for Path to Cures. 

More books from Springer International Publishing

Cover of the book Adoption in the Digital Age by
Cover of the book Public Representations of Immigrants in Museums by
Cover of the book Inclusive Governance in South Asia by
Cover of the book Women Phenomenologists on Social Ontology by
Cover of the book Carbon Nanotubes for Clean Water by
Cover of the book Radio Frequency Channel Coding Made Easy by
Cover of the book Right Heart Pathology by
Cover of the book An Ecological Theory of Free Expression by
Cover of the book Uncertainty Quantification in Computational Fluid Dynamics by
Cover of the book Eco-Socialism For Now and the Future by
Cover of the book Physiological Aspects of Legged Terrestrial Locomotion by
Cover of the book Saudi Aramco 2030 by
Cover of the book Surveillance, Race, Culture by
Cover of the book Web, Artificial Intelligence and Network Applications by
Cover of the book Nordic States and European Integration by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy